Market capitalization | $2.76b |
Enterprise Value | $2.71b |
P/E (TTM) P/E ratio | 39.00 |
EV/FCF (TTM) EV/FCF | 54.66 |
EV/Sales (TTM) EV/Sales | 1.70 |
P/S ratio (TTM) P/S ratio | 1.73 |
P/B ratio (TTM) P/B ratio | 3.94 |
Revenue growth (TTM) Revenue growth | 22.76% |
Revenue (TTM) Revenue | $1.59b |
As a Free StocksGuide user, you can view scores for all 6,900 stocks worldwide.
8 Analysts have issued a Astrana Health forecast:
8 Analysts have issued a Astrana Health forecast:
Jun '24 |
+/-
%
|
||
Revenue | 1,592 1,592 |
23%
23%
|
|
Gross Profit | 237 237 |
17%
17%
|
|
EBITDA | 117 117 |
9%
9%
|
EBIT (Operating Income) EBIT | 95 95 |
15%
15%
|
Net Profit | 68 68 |
38%
38%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It operates as an integrated healthcare delivery platform, providing services like Primary Care, Multi-Specialty Care, Immediate Care, Radiology, and Laboratory. The company was founded by Kenneth Sin and Thomas S. Lam on November 1, 1985 and is headquartered in Alhambra, CA.
Head office | United States |
CEO | Brandon Sim |
Employees | 1,800 |
Founded | 1985 |
Website | www.astranahealth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.